CN1533271A - 在光化疗法中作为光敏化剂的5-氨基乙酰丙酸及其酯与另一光敏剂的组合,以及它们在治疗创伤中的用途 - Google Patents

在光化疗法中作为光敏化剂的5-氨基乙酰丙酸及其酯与另一光敏剂的组合,以及它们在治疗创伤中的用途 Download PDF

Info

Publication number
CN1533271A
CN1533271A CNA028145801A CN02814580A CN1533271A CN 1533271 A CN1533271 A CN 1533271A CN A028145801 A CNA028145801 A CN A028145801A CN 02814580 A CN02814580 A CN 02814580A CN 1533271 A CN1533271 A CN 1533271A
Authority
CN
China
Prior art keywords
ala
photosensitizer
ester
ala ester
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028145801A
Other languages
English (en)
Chinese (zh)
Inventor
J
J·克莱威尼斯
V·汉森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure ASA filed Critical Photocure ASA
Publication of CN1533271A publication Critical patent/CN1533271A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA028145801A 2001-07-26 2002-07-25 在光化疗法中作为光敏化剂的5-氨基乙酰丙酸及其酯与另一光敏剂的组合,以及它们在治疗创伤中的用途 Pending CN1533271A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0118251.8 2001-07-26
GBGB0118251.8A GB0118251D0 (en) 2001-07-26 2001-07-26 Method

Publications (1)

Publication Number Publication Date
CN1533271A true CN1533271A (zh) 2004-09-29

Family

ID=9919248

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028145801A Pending CN1533271A (zh) 2001-07-26 2002-07-25 在光化疗法中作为光敏化剂的5-氨基乙酰丙酸及其酯与另一光敏剂的组合,以及它们在治疗创伤中的用途

Country Status (13)

Country Link
US (1) US20040259949A1 (enExample)
EP (1) EP1414430A2 (enExample)
JP (1) JP2005501050A (enExample)
KR (1) KR20040030863A (enExample)
CN (1) CN1533271A (enExample)
CA (1) CA2454136A1 (enExample)
CZ (1) CZ2004257A3 (enExample)
GB (1) GB0118251D0 (enExample)
HU (1) HUP0401192A3 (enExample)
MX (1) MXPA04000647A (enExample)
NO (1) NO20040321L (enExample)
RU (1) RU2004105655A (enExample)
WO (1) WO2003011265A2 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101056626B (zh) * 2004-11-10 2011-12-14 弗托库尔公司 利用5-氨基乙酰丙酸衍生物治疗痤疮
CN103717215A (zh) * 2011-06-16 2014-04-09 思佰益药业股份有限公司 过敏性鼻炎的治疗剂
CN105288619A (zh) * 2008-04-04 2016-02-03 免疫之光有限责任公司 用于原位光生物调节的非侵入性系统和方法
CN105555312A (zh) * 2013-06-19 2016-05-04 思佰益药业股份有限公司 用于促进生成原卟啉ix的药物组合物
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CN112062713A (zh) * 2020-08-04 2020-12-11 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
NL1020336C2 (nl) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Toepassing van een verbinding voor de bereiding van een farmaceutisch preparaat voor het behandelen van brandwonden, en een werkwijze voor het behandelen van brandwonden.
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
TR200504022T1 (tr) * 2003-03-24 2006-08-21 Hetero Drugs Limited (S)-sitalopram oksalatın yeni sıvı kristal formları.
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0420888D0 (en) * 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
ATE454146T1 (de) * 2006-08-29 2010-01-15 Stichting Tech Wetenschapp Pharmazeutische zusammensetzung zur behandlung von mykotischen hauterkrankungen und verfahren zu ihrer herstellung
JP2011506425A (ja) * 2007-12-14 2011-03-03 フォトデルマ エスアー 治療的及び美容的方法に有用な新規化合物
RU2395315C1 (ru) * 2008-12-01 2010-07-27 Государственное унитарное предприятие г. Москвы Международный научный и клинический центр "Интермедбиофизхим" (ГУП МНКЦ "Интермедбиофизхим") Способ фотодинамической терапии гнойных ран и трофических язв
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
CN102458388B (zh) 2009-06-11 2016-09-28 光治疗Asa公司 半固体组合物及药物制品
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
JP2013521251A (ja) 2010-03-01 2013-06-10 フォトキュア エイエスエイ 美容組成物
EP2585111A1 (en) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
BR112013000613A2 (pt) 2010-07-09 2016-06-28 Photocure Asa composições secas e dispositivos que contêm tais composições secas
WO2012012616A1 (en) * 2010-07-21 2012-01-26 Patty-Fu Giles Photoactive vitamin nanoparticles for the treatment of chronic wounds
US20140056964A1 (en) * 2010-12-06 2014-02-27 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
CN104152530B (zh) 2010-12-24 2017-09-19 爱科来株式会社 癌细胞的检测方法
KR101254752B1 (ko) * 2011-02-28 2013-04-15 부산대학교 산학협력단 광역동치료의 광증감제로 사용하기 위한 구연산을 이용한 아미노레불리닉산 트라이머
KR101254758B1 (ko) * 2011-02-28 2013-04-15 부산대학교병원 광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
US20140276107A1 (en) 2011-10-14 2014-09-18 Photocure Asa Photodynamic diagnosis
EP2779956A1 (en) 2011-10-14 2014-09-24 Photocure ASA Stent
WO2013092505A1 (en) 2011-12-19 2013-06-27 Photocure Asa Irradiation apparatus
CA2888241C (en) 2012-10-16 2020-12-29 Surmodics, Inc. Wound packing device and methods
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
RU2604399C1 (ru) * 2015-12-01 2016-12-10 Сергей Владимирович Москвин Способ лазерной терапии больных трофическими язвами
RU2661084C1 (ru) * 2017-07-21 2018-07-11 Федеральное Агентство Научных Организаций Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ комплексного лечения пролежней у пациентов с длительной иммобилизацией

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101056626B (zh) * 2004-11-10 2011-12-14 弗托库尔公司 利用5-氨基乙酰丙酸衍生物治疗痤疮
CN105288619A (zh) * 2008-04-04 2016-02-03 免疫之光有限责任公司 用于原位光生物调节的非侵入性系统和方法
CN103717215A (zh) * 2011-06-16 2014-04-09 思佰益药业股份有限公司 过敏性鼻炎的治疗剂
CN103717215B (zh) * 2011-06-16 2016-08-17 思佰益药业股份有限公司 过敏性鼻炎的治疗剂
CN105555312A (zh) * 2013-06-19 2016-05-04 思佰益药业股份有限公司 用于促进生成原卟啉ix的药物组合物
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CN112062713A (zh) * 2020-08-04 2020-12-11 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用

Also Published As

Publication number Publication date
CA2454136A1 (en) 2003-02-13
WO2003011265A2 (en) 2003-02-13
WO2003011265A3 (en) 2003-04-24
CZ2004257A3 (cs) 2004-08-18
KR20040030863A (ko) 2004-04-09
HUP0401192A2 (hu) 2004-12-28
US20040259949A1 (en) 2004-12-23
RU2004105655A (ru) 2005-04-10
NO20040321L (no) 2004-03-19
GB0118251D0 (en) 2001-09-19
HUP0401192A3 (en) 2005-07-28
MXPA04000647A (es) 2004-05-17
JP2005501050A (ja) 2005-01-13
EP1414430A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
CN1533271A (zh) 在光化疗法中作为光敏化剂的5-氨基乙酰丙酸及其酯与另一光敏剂的组合,以及它们在治疗创伤中的用途
JP5814508B2 (ja) アミノレブリン酸およびその誘導体の使用
EP1814534B1 (en) Derivatives of 5-aminolevulinic acid for the treatment of acne
Chen et al. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5‐aminolevulinic acid‐mediated photodynamic therapy
JP2004505040A (ja) 組成物
CN105555312A (zh) 用于促进生成原卟啉ix的药物组合物
WO2007086395A1 (ja) 光線力学的療法用キット
AU2002317980A1 (en) 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their use in treating wounds
Zovinka et al. Photochemotherapy: Light-dependent therapies in medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication